News & Events

News

Oriens Capital partners with Hamilton based IVS Group
Oriens Capital partners with Hamilton based IVS Group

The Oriens Capital Private Equity Fund LP has agreed to an unconditional investment transaction into Hamilton based IVS Group Holdings (IVS). The transaction will see Oriens Capital partner with IVS Group’s founder, Peter Webb, and his family interests. Peter will remain CEO of the Group which encompasses Independent Verification Services, IVS Labs and IVS Training. Following completion, Oriens Capital will own a 70% shareholding with Webb interests retaining 30%.

IVS is extremely well positioned as an integral partner to New Zealand’s international trade sector. IVS demonstrated excellent resilience during 2020, a challenging year for all, and is well positioned for future growth.

Peter Webb said that the Oriens Capital investment would help the company deliver on its strategic growth opportunities both domestically and internationally.

“Oriens brings sector relevant relationships, plus capability and capital to support bolt on acquisitions. It is an exciting time for IVS and we look forward to growing the company considerably over the next few years”.

Oriens Capital CEO James Beale commented that IVS will be the last investment in Oriens’ first fund, and final preparations for a second fund are well underway.

About IVS Group Holdings

IVS Group (IVS) is a multifaceted Hamilton based business that supports and facilitates trade, focused on ensuring New Zealand industry continues to grow and prosper, whilst protecting the New Zealand environment for future generations.

Encompassing biosecurity, certification, testing and training, IVS is fully embedded into the regulatory processes and supply chains of New Zealand’s trade sectors.

About Oriens Capital

Established in 2016, Oriens Capital is a Tauranga based private equity fund with committed capital of $50.6m in Fund 1. Oriens Capital targets investments in private businesses with enterprise values between $10m and $50m, providing both expansion (growth) and succession (buyout) capital. Fund 1 has made 6 investments, into Rockit Global, Bluelab, Retirement Income Group, About Health, Rhino Manufacturing and IVS. Oriens Capital is preparing to raise its second Fund shortly.